水凝胶负载药物治疗心肌梗死  

Hydrogel with Drugs for Myocardial Infarction

作　　者：柳成荫 蒋学俊[1] LIU Chengyin;JIANG Xuejun(Department of Cardiology,Renmin Hospital of Wuhan University,Cardiovascular Research Institute,Wuhan University,Hubei Key Laboratory of Cardiology,Wuhan 430060,Hubei,China)

机构地区：[1]武汉大学人民医院心内科武汉大学心血管病研究所心血管病湖北省重点实验室,湖北武汉430060

出　　处：《心血管病学进展》2021年第6期496-498,共3页Advances in Cardiovascular Diseases

基　　金：湖北省中央引导地方科技发展专项基金(2019ZYYD062)。

摘　　要：急性心肌梗死仍是严重影响人类健康的主要疾病之一。水凝胶材料因为能提供与天然心肌相似的生物性、机械力性、导电性和化学性能,在心肌梗死治疗上有潜在价值。水凝胶携带药物,可以长时间保持高浓度的活性药物成分,为药物输送提供了方便的载体。这使得水凝胶成为一种非常有效的治疗心肌梗死的药物输送系统。现综述水凝胶携带药物治疗心肌梗死的相关研究。Acute myocardial infarction is still one of the diseases that affect human health.Because it can provide properties which similar to natural myocardium,hydrogel materials have potential value in the treatment of myocardial infarction.Hydrogel can carry medicine to maintain high concentration of active pharmaceutical ingredients,which makes hydrogel a very effective drug delivery system for treating myocardial infarction.This article focuses on the hydrogel with drugs for myocardial infarction therapy.

关 键 词：心肌梗死 水凝胶 药物 血管再生 

分 类 号：R54[医药卫生—心血管疾病]